These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34247461)

  • 1. Nondamaging retinal laser therapy in recurrent diabetic macular edema after antiVEGF injections.
    Çıtırık M
    Turk J Med Sci; 2021 Oct; 51(5):2616-2620. PubMed ID: 34247461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
    Pieramici DJ; Wang PW; Ding B; Gune S
    Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
    Kim M; Lee P; Kim Y; Yu SY; Kwak HW
    Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of central foveal thickness on the efficacy of subthreshold micropulse yellow laser photocoagulation in diabetic macular edema.
    Citirik M
    Lasers Med Sci; 2019 Jul; 34(5):907-912. PubMed ID: 30368640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of selective retina therapy for diabetic macular edema based on pretreatment central foveal thickness.
    Kim M; Park YG; Jeon SH; Choi SY; Roh YJ
    Lasers Med Sci; 2020 Oct; 35(8):1781-1790. PubMed ID: 32095921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
    Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
    BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.
    Sophie R; Lu N; Campochiaro PA
    Ophthalmology; 2015 Jul; 122(7):1395-401. PubMed ID: 25870079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab - One-year real-life results in Taiwan.
    Lai TT; Yang CM; Yang CH; Ho TC; Hsieh YT
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):194-202. PubMed ID: 29609918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
    Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
    Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflibercept 5+PRN with retinal laser photocoagulation is more effective than retinal laser photocoagulation alone and aflibercept 3+PRN with retinal laser photocoagulation in patients with high-risk proliferative diabetic retinopathy and diabetic macular edema: a 12-month clinical trial.
    Li S; Tao Y; Yang M; Zhao H; Si M; Cui W; Wang H
    Front Endocrinol (Lausanne); 2024; 15():1286736. PubMed ID: 38455651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
    Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept.
    Chen YY; Chang PY; Wang JK
    Asia Pac J Ophthalmol (Phila); 2017; 6(3):250-255. PubMed ID: 28436640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthreshold laser treatment for non-center involved diabetic macular edema via non-damaging retinal laser therapy (NRT).
    Akkan Aydogmus FS; Kalayci D; Polat Gultekin B
    Int Ophthalmol; 2024 Mar; 44(1):129. PubMed ID: 38472440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
    Fu Y; Wang P; Meng X; Du Z; Wang D
    Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
    Laugesen CS; Ostri C; Brynskov T; Lund-Andersen H; Larsen M; Vorum H; Sørensen TL
    Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M; Yamashita M; Ogata N
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema.
    Chen YY; Chen PY; Chen FT; Chen YJ; Wang JK
    Int Ophthalmol; 2018 Feb; 38(1):293-299. PubMed ID: 28176171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation of the subthreshold micropulse laser combined with ranibizumab for treatment of diabetic macular edema].
    Gu XY; Song S; Dai H; Yu XB
    Zhonghua Yan Ke Za Zhi; 2024 Jul; 60(7):570-579. PubMed ID: 38955759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.